Abstract:Background Signal transducer and activator of transcription 3 (STAT3) is usually constitutively activated in a variety of malignancies. Therefore, STAT3 may be a promising target for treatment of tumor cells. To explore the possibility of a double-stranded decoy oligodeoxynucleotide (ODN) targeted blocking STAT3 over-activated tumor cells, we, here, evaluate the efficacy of STAT3 decoy ODN on human lung cancer cells in vitro and in vivo . Methods A STAT3 decoy ODN was transfected into A549 lung cancer cell line in vitro by using lipofectamine. The flow cytometry and fluorescent microscopy were used to detect the transfection efficiency and the sub-cellular localization of STAT3 decoy ODN in A549 cells. Cell proliferation was determined by counting cell numbers and [ 3 H]-thymidine uptake. Cell apoptosis was examined with Annexin V and propidum iodide by flow cytometry. The expression levels of STAT3 target genes were identified by RT-PCR and immunoblot. For in vivo experiment, A549 lung carcinoma-nude mice xenograft was used as a model to examine the effect of the STAT3 decoy by intratumoral injection. At the end of treatment, TUNEL and immunohistochemistry were used to examine the apoptosis and the expression levels of bcl-xl and cyclin D1 in tumor tissues. Results STAT3 decoy ODN was effectively transfected into A549 lung cancer cells and mainly located in nucleus. STAT3-decoy ODN significantly induced apoptosis and reduced [ 3 H]-thymidine incorporation of A549 cells as well as down-regulated STAT3-target genes in vitro . STAT3 decoy ODN also dramatically inhibited the lung tumor growth in xenografted nude mice and decreased gene expression of bcl-xl and cyclin D1. Conclusion STAT3 decoy ODN significantly suppressed lung cancer cells in vitro and in vivo , indicating that STAT3 decoy ODN may be a potential therapeutic approach for treatment of lung cancer.

An experimental study on decoy oligodeoxynucleotides targeting activated STAT3 to suppress bladder cancer cell growth

Therapeutic Effects of Stat3 Decoy Oligodeoxynucleotide on Human Lung Cancer in Xenograft Mice

Knockdown of STAT3 Expression in SKOV3 Cells by Biodegradable Sirna–plga/cso Conjugate Micelles

STAT3-decoy Oligodeoxynucleotide Inhibits the Growth of Human Lung Cancer Via Down-Regulating Its Target Genes

Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells

Inhibition of TGF-β by siRNA Suppresses the Motility and Invasiveness of T24 Bladder Cancer Cells

A Small Molecule Compound Targeting STAT3 DNA-Binding Domain Inhibits Cancer Cell Proliferation, Migration, and Invasion

Growth Inhibition of Human Hepatocellular Carcinoma Cells by Blocking STAT3 Activation with Decoy-Odn.

Combined Inhibition of PI3K and STAT3 signaling effectively inhibits bladder cancer growth

Effects of STAT3 Gene Silencing by ShRNA on Human Colorectal Cancer Cells

Down-Regulation Of Signal Transducer And Activator Of Transcription 3 Expression Using Vector-Based Small Interfering Rnas Suppresses Growth Of Human Prostate Tumor In Vivo

Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3

The Influence of STAT3 Silencing by RNA Interference on the Biological Characteristics of Eca-109 Cell Line

Effects on the STAT3-shRNA in Non-Small-Cell Lung Cancer Therapy: Design, Induction of Apoptosis, and Conjugation with Chitosan-Based Gene Vectors

Stat3 Inhibitors TTI-101 and SH5-07 Suppress Bladder Cancer Cell Survival in 3D Tumor Models

Efficacy of recombinant Bacillus Calmette-Guérin containing dltA in in vivo three-dimensional bio-printed bladder cancer-on-a-chip and ex vivo orthotopic mouse model

Small-molecule Compounds Targeting the STAT3 DNA-binding Domain Suppress Survival of Cisplatin-Resistant Human Ovarian Cancer Cells by Inducing Apoptosis.

Inhibitory Effect of Recombinant TGF alpha-PE40 Combined with survivin Antisense Oligonucleotides on Bladder Transitional Cell Carcinoma Cells

STAT3 signaling pathway in drug-resistant bladder cancer cell line

A preliminary study of AS1411 mediated STAT3 antisense oligonucleotide targeting tumor cells

Design, synthesis, and biological evaluation of naphthoylamide derivatives as inhibitors of STAT3 phosphorylation